跳至主要内容
临床试验/ISRCTN21335883
ISRCTN21335883已完成未知

A randomised controlled trial assessing the impact of a Low Calorie Diet on weight loss in obese patients with type 2 Diabetes Mellitus treated with insulin

Imperial College London (UK)0 个研究点目标入组 90 人开始时间: 2012年10月23日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32049634/ results (added 03/06/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current inclusion criteria as of 23/07/2015:
  • 1. Have BMI >30 kg/m²
  • 2. Men or women
  • 3. Age 18-70 years
  • 4. Are willing and able to give informed consent for participation in the study
  • 5. Have been on insulin treatment < 10 years or greater than 10 years with a fasting c-peptide of >600
  • Previous inclusion criteria from 11/09/2014 to 23/07/2015:
  • 1. Have BMI >30 kg/m²
  • 2. Men or women
  • 3. Age 18-70 years
  • 4. Are willing and able to give informed consent for participation in the study
  • 5. Have been on insulin treatment < 10 years
  • Original inclusion criteria:
  • 1. Have BMI >30 kg/m²
  • 2. Men or women
  • 3. Age 18-70 years
  • 4. Are willing and able to give informed consent for participation in the study
  • 5. Have been on insulin treatment < 4 years

排除标准

  • Current exclusion criteria as of 23/07/2015:
  • 1. Have type 1 diabetes
  • 2. Any significant diabetes microvascular complication
  • 3. Are unable to provide written informed consent
  • 4. Have experienced a cardiovascular disease (CVD) event in the previous 6 months
  • 5. Are at stage 4 chronic kidney disease or greater (eGFR <30 mL/min/1.73 m²)
  • 6. Have a mental incapacity, unwillingness and/or inability to understand, and be able to complete the mental health questionnaires in the provided language
  • 7. Currently pregnant, lactating, or planning pregnancy within the study period
  • 8. Have binge eating behaviour (will be assessed by Dutch Eating Behaviour Questionnaire)
  • 9. Patient has condition precipitating fluid overload such as heart failure (New York Heart Association grade III-IV) and liver cirrhosis
  • 10. Are using medication clinically deemed to affect metabolic rate and weight (e.g. beta blockers, corticosteroids, diuretics, etc)
  • 11. Have significant psychiatric disorder (e.g. schizophrenia, anxiety, panic disorder, ADHD/ADD, post-traumatic stress disorder, obsessive-compulsive disorder)
  • 12. Uncontrolled depression
  • 13. Have participated in a weight management drug trial in the previous 3 months
  • 14. Difficult to control International Normalising Ratio (INR) within the therapeutic range
  • 15. Have uncontrolled epilepsy
  • 16. Are known or suspected of substance use
  • 17. Are lactose intolerant
  • 18. Severe musculoskeletal conditions preventing walking
  • 20. Have active gallstone disease or known asymptomatic gallstones
  • 21. Clinically assessed hypoglycaemia unawareness
  • 22. On ECG evidence of left bundle branch block
  • Previous exclusion criteria from 11/09/2014 to 23/07/2015:
  • 1. Have type 1 diabetes
  • 2. Any significant diabetes microvascular complication
  • 3. Are unable to provide written informed consent
  • 4. Have experienced a cardiovascular disease (CVD) event in the previous 6 months
  • 5. Are at stage 4 chronic kidney disease or greater (eGFR <30 mL/min/1.73 m²)
  • 6. Have a mental incapacity, unwillingness and/or inability to understand, and be able to complete the mental health questionnaires in the provided language
  • 7. Currently pregnant, lactating, or planning pregnancy within the study period
  • 8. Have binge eating behaviour (will be assessed by Dutch Eating Behaviour Questionnaire)
  • 9. Patient has condition precipitating fluid overload such as heart failure (New York Heart Association grade III-IV) and liver cirrhosis
  • 10. Are using medication clinically deemed to affect metabolic rate and weight (e.g. beta blockers, corticosteroids, diuretics, etc)
  • 11. Have significant psychiatric disorder (e.g. schizophrenia, anxiety, panic disorder, ADHD/ADD, post-traumatic stress disorder, obsessive-compulsive disorder)
  • 12. Uncontrolled depression
  • 13. Have participated in a weight management drug trial in the previous 3 months
  • 14. Are on anticoagulant medication - excluding aspirin or clopidogrel
  • 15. Have uncontrolled epilepsy
  • 16. Are known or suspected of substance use
  • 17. Are lactose intolerant
  • 18. Severe musculoskeletal conditions preventing walking
  • 20. Have active gallstone disease or known asymptomatic gallstones
  • 21. Clinically assessed hypoglycaemia unawareness
  • 22. On ECG evidence of left bundle branch block
  • Original exclusion criteria:
  • 1. Have type 1 diabetes
  • 2. Have any significant diabetes microvascular complication
  • 3. Are unable to provide written informed consent
  • 4. Have experienced a cardiovascular disease (CVD) event in the previous 6 months

研究者

发起方
Imperial College London (UK)

相似试验

ow calorie diet in obese type 2 diabetes patients... | 临床试验